Search Results

5 items found for "Revelar Biotherapeutics"

Dynamic Phosphoproteomics of BRS3 Activation Reveals the Hippo Signaling Pathway for Cell Migration
< GPCR News < GPCRs in Oncology and Immunology Dynamic Phosphoproteomics of BRS3 Activation Reveals the Data analysis revealed that 27 phosphopeptides corresponding to six proteins were involved in the Hippo
Distinct Activation Mechanisms of CXCR4 and ACKR3 Revealed by Single-Molecule Analysis of their Conformational Landscapes
< GPCR News < GPCRs in Oncology and Immunology Distinct Activation Mechanisms of CXCR4 and ACKR3 Revealed The data revealed that apo-CXCR4 preferentially populates a high-FRET inactive state, while apo-ACKR3
Systems modeling of oncogenic G-protein and GPCR signaling reveals unexpected differences in downstream pathway activation
News < GPCRs in Oncology and Immunology Systems modeling of oncogenic G-protein and GPCR signaling reveals Modeling the two major, mutually-exclusive, oncogenic mutations (Gαq/11 and CysLT2R) revealed the potential
Unbiased multitissue transcriptomic analysis reveals complex neuroendocrine regulatory networks mediated by spinal cord injury-induced immunodeficiency
< GPCR News < GPCRs in Oncology and Immunology Unbiased multitissue transcriptomic analysis reveals complex
RNAi library screening reveals Gβ1, Casein Kinase 2 and ICAP-1 as novel regulators of LFA-1-mediated T cell polarity and migration
< GPCR News < GPCRs in Oncology and Immunology RNAi library screening reveals Gβ1, Casein Kinase 2 and pathway analysis, three of these genes were characterized in further detail using primary human T cells, revealing Knockdown of ICAP-1 expression in primary T cells revealed a role in cell polarity, cell velocity and